- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 227/02 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 227/02
Total number of patents in this class: 17
10-year publication summary
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cedilla Therapeutics, Inc. | 26 |
3 |
| New York University | 1840 |
2 |
| Pillai Universal LLC | 18 |
2 |
| Novartis AG | 10263 |
1 |
| Universiteit Antwerpen | 410 |
1 |
| Universiteit Gent | 1401 |
1 |
| Vib VZW | 902 |
1 |
| Guizhou Entry-exit Inspection and Quarantine Bureau | 1 |
1 |
| Guizhou Medical University | 10 |
1 |
| Maternal and Child Health Hospital of Guiyang City | 1 |
1 |
| Design Therapeutics Inc. | 55 |
1 |
| Merck Sharp & Dohme LLC | 3735 |
1 |
| Variational AI Inc. | 4 |
1 |
| Other owners | 0 |